Target intelligence / Profile preview

Cell division cycle protein 27 homolog (CDC27)

Target
CDC27
Molecular classification
Enzyme (specifically, E3 ubiquitin-protein ligase complex subunit), Other (Multisubunit cell cycle complex subunit)
01

Overview

Cell division cycle protein 27 homolog (CDC27) is an essential subunit of the anaphase-promoting complex/cyclosome (APC/C), a large E3 ubiquitin ligase that regulates cell cycle progression by targeting key cell cycle proteins such as cyclin B and securin for proteasomal degradation[3][4][5][1]. CDC27 contains tetratricopeptide repeat (TPR) domains, enabling interactions with mitotic checkpoint proteins (such as Mad2, BubR1, p55CDC) and recruitment of coactivators CDC20 and CDH1, both of which are crucial for proper timing of mitosis and G1 phase transition[2][3][5][6][1]. Dysregulation of CDC27 or APC/C complex function contributes to genomic instability and is associated with the development of cancer and related cell cycle disorders[6][5]. No approved therapeutics directly target CDC27/APC3; however, the APC/C complex is an emerging cancer drug target[6].

Other names
ANAPC3APC3CDC27HsD0S1430ED17S978EH-NUCHNUCNUC2cell division cycle 27anaphase-promoting complex subunit 3nuc2 homolog
02

Mechanism of action

Inhibition or modulation of APC/C complex activity (notably through targeting its E3 ligase function) Modulation of substrate ubiquitination and degradation (indirect, as APC/C is not yet a direct drug target)

03

Biological functions

Cell cycle regulationMitosis progressionUbiquitin-mediated proteolysisChromosome segregationRegulation of mitotic exit
04

Disease associations

CancerOther (DNA replication disorders, cell cycle-related diseases)
05

Safety considerations

Targeting CDC27/APC/C may cause cell cycle arrest or genomic instability, resulting in possible toxicity to proliferating normal tissuesDisruption of APC/C can contribute to aneuploidy and tumorigenesis
06

Biomarkers

Potential biomarker for cell proliferation status (used in cancer research to study cell cycle activity, not as a routine clinical marker)[5]

Beyond the preview

Go deeper on Cell division cycle protein 27 homolog (CDC27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell division cycle protein 27 homolog (CDC27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call